Investors

OvaScience is a global fertility company dedicated to improving treatment options for women around the world.

OVAS (Common Stock)
Price & Exchange
$8.28
NASDAQ
Change (%)
 Stock is Down 0.1 (1.19%)
Volume
289,459
05/02/16      4:00 p.m. ET

Minimum 20 minute delay
Refresh quote

Investor Overview

Recent News

More »
DateTitle 
04/28/16OvaScience to Host First Quarter 2016 Financial Results Conference Call
WALTHAM, Mass.--(BUSINESS WIRE)--Apr. 28, 2016-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it will host a conference call at 4:30 p.m. EDT on Thursday, May 5, 2016 to discuss first quarter 2016 financial results and provide a general corporate update. The live call can be accessed by dialing +1 888 424 8151 for U.S. call... 
Printer Friendly Version
03/31/16OvaScience Announces Senior Management Changes and Appointments
– Arthur Tzianabos, Ph.D., Departs as President and Chief Scientific Officer; James D. Luterman, Ph.D., Appointed Senior Vice President, Research & Development – WALTHAM, Mass.--(BUSINESS WIRE)--Mar. 31, 2016-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Arthur Tzianabos, Ph.D., has stepped down as President and Chief Sci... 
Printer Friendly Version
03/09/16OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--Mar. 9, 2016-- OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today the grant of inducement awards to its newly appointed Chief Operating Officer, Paul Chapman, and newly appointed Executive Vice President of Corporate Communications, Rebecca Peterson. The awards were approved by the Board's Compensation Committee ... 
Printer Friendly Version
03/07/16OvaScience to Present at Cowen and Company Health Care Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Mar. 7, 2016-- OvaScienceSM (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that Company management will present at the Cowen and Company 36th Annual Health Care Conference on Wednesday, March 9, 2016 at 8:00 a.m. ET at the Boston Marriott Copley Place in Boston, MA. A live audio webcast of the presentation can b... 
Printer Friendly Version

Upcoming Events

More »
DateTitle
05/05/16 4:30 p.m. ET
Q1 2016 Ovascience Inc Earnings Conference Call
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources